UnitedHealth Group (NYSE:UNH) Shares Climb 2% Following Analyst Upgrade

UnitedHealth Group Incorporated (NYSE:UNH) traded up 2% during mid-day trading on Thursday after Mizuho raised their price target on the stock from $493.00 to $500.00. Mizuho currently has an outperform rating on the stock. UnitedHealth Group traded as high as $426.55 and last traded at $425.2860. Approximately 5,412,030 shares changed hands during mid-day trading, a decline of 26% from the average session volume of 7,356,971 shares. The stock had previously closed at $417.00.

A number of other research firms have also commented on UNH. Bank of America reaffirmed a “buy” rating and set a $450.00 price target on shares of UnitedHealth Group in a research report on Monday, July 20th. Argus lifted their price objective on UnitedHealth Group from $400.00 to $470.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. KeyCorp restated an “overweight” rating on shares of UnitedHealth Group in a report on Wednesday, October 14th. Raymond James Financial reaffirmed an “outperform” rating and issued a $450.00 price target on shares of UnitedHealth Group in a research note on Thursday, October 15th. Finally, New Street Research set a $402.00 price target on shares of UnitedHealth Group in a report on Friday, October 9th. Twenty analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $463.80.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares in the company, valued at $5,977,920. This trade represents a 7.09% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.19% of the stock is owned by corporate insiders.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Strong third-quarter results support the recovery. Adjusted earnings per share rose approximately 61%, while the medical care ratio improved to 88.4%, indicating that UnitedHealth retained more premium revenue after covering medical costs. Management also raised its full-year outlook, reinforcing expectations for better profitability. UnitedHealth’s Earnings Jumped 60%. Is the Comeback Stock a Buy, Sell, or Hold?
• Positive Sentiment: Mizuho raised its price target. The firm increased its target from $493 to $500 and maintained an “outperform” rating, signaling confidence that earnings improvement and the company’s turnaround can continue. Mizuho UnitedHealth rating
• Positive Sentiment: Valuation and operating leverage are attracting investors. Zacks characterized UNH as a strong value stock, while a separate analysis argued that operating leverage could drive additional earnings growth. Increased investor attention and generally bullish Wall Street recommendations are also supporting sentiment. Why UnitedHealth Is a Strong Value Stock
• Neutral Sentiment: Optum provides earnings diversification, but not complete protection. Optum contributed roughly half of UnitedHealth’s reported second-quarter operating earnings, although medical inflation and Medicare funding pressure affect both its insurance and healthcare-services businesses. Does Optum Truly Diversify Its Earnings Risk?
• Negative Sentiment: Higher Medicare costs could pressure demand and political sentiment. UnitedHealth is expected to raise 2027 Medicare costs for seniors, while older Americans are already facing higher healthcare expenses. Increased premiums and prescription-drug costs could create affordability concerns and regulatory scrutiny. UnitedHealth Will Raise 2027 Medicare Costs
• Negative Sentiment: Healthcare-sector weakness remains a near-term headwind. Healthcare stocks moved lower late Wednesday, suggesting that some of UNH’s gains may remain vulnerable to sector-wide trading pressure. Healthcare Stocks Softer Late Afternoon

Institutional Investors Weigh In On UnitedHealth Group

Several large investors have recently bought and sold shares of UNH. City State Bank raised its holdings in shares of UnitedHealth Group by 5.6% during the third quarter. City State Bank now owns 471 shares of the healthcare conglomerate’s stock valued at $173,000 after purchasing an additional 25 shares during the last quarter. LFG Wealth Partners LLC raised its stake in UnitedHealth Group by 3.3% during the 2nd quarter. LFG Wealth Partners LLC now owns 853 shares of the healthcare conglomerate’s stock valued at $355,000 after buying an additional 27 shares during the last quarter. Synergy Financial Group LTD lifted its holdings in shares of UnitedHealth Group by 3.1% during the 2nd quarter. Synergy Financial Group LTD now owns 887 shares of the healthcare conglomerate’s stock valued at $369,000 after buying an additional 27 shares during the period. Ares Financial Consulting LLC lifted its holdings in UnitedHealth Group by 7.2% in the second quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate’s stock valued at $174,000 after acquiring an additional 28 shares during the period. Finally, Hudock Inc. boosted its position in UnitedHealth Group by 1.0% in the second quarter. Hudock Inc. now owns 2,844 shares of the healthcare conglomerate’s stock worth $1,182,000 after purchasing an additional 28 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Up 2.0%

The company’s 50 day moving average price is $387.63 and its two-hundred day moving average price is $388.48. The stock has a market cap of $381.73 billion, a P/E ratio of 24.29, a PEG ratio of 1.51 and a beta of 0.60. The company has a current ratio of 0.74, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. The business had revenue of $112.70 billion during the quarter, compared to analysts’ expectations of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The business’s quarterly revenue was down .4% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 20.64 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group’s dividend payout ratio (DPR) is 53.00%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.